1. "I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain. Issue 8 (9th August 2021) Authors: Mantsios, Andrea; Murray, Miranda; Karver, Tahilin S.; Davis, Wendy; Margolis, David; Kumar, Princy; Swindells, Susan; Bredeek, U. Fritz; Deltoro, Miguel García; García, Rafael Rubio; Antela, Antonio; Garris, Cindy; Shaefer, Mark; Gomis, Santiago Cenoz; Bernáldez, Miguel Pascual; Kerrigan, Deanna Journal: Culture, health & sexuality Issue: Volume 23:Issue 8(2021) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1034. Patient Perspectives on Implementation of a Long-Acting Injectable Antiretroviral Therapy Regimen in HIV US Healthcare Settings: Interim Results from the CUSTOMIZE study. (31st December 2020) Authors: Garris, Cindy; D'Amico, Ronald; Wannamaker, Paul; Mpofu, Nobuhle; McHorney, Colleen A; Mansukhani, Sonal; Flamm, Jason; Thedinger, Blair; Benson, Paul; Chiriboga-Salazar, Daniela M; Czarnogorski, Maggie Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV treatment in the US (CUSTOMIZE). (31st December 2020) Authors: Czarnogorski, Maggie; Garris, Cindy; Wannamaker, Paul; D'Amico, Ronald; Selenski, Carolyn; Williams, Will; McHorney, Colleen A; Stassek, Larissa; Wohlfeiler, Michael; Sinclair, Gary I; Mena, Leandro A; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1254. An Increase in Single-tablet Regimen (STR) Utilization for People Living with HIV (PLWH) Enrolled in Medicaid had Minimal Impact on Pharmacy Costs. (15th December 2022) Authors: Brogan, Andrew P; Garris, Cindy; Priest, Julie; Divino, Victoria; He, Jing; Chen, Justin; DeKoven, Mitch Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1255. Single-tablet Regimens (STR) Offer Better Persistence and Adherence, with Lower Costs by Adherence Status, than Multiple-tablet Regimens (MTR) for People Living with HIV (PLWH) Enrolled in Medicaid. (15th December 2022) Authors: Brogan, Andrew P; Garris, Cindy; Priest, Julie; Divino, Victoria; He, Jing; Chen, Justin; DeKoven, Mitch Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1288. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND). (15th December 2022) Authors: Hsu, Ricky K; Phoenix, John; Sinclair, Gary I; Gupta, Samir K; Puga, Ana; Nguyen, Kaitlin; Schubert, Catherine K; Merrill, Deanna; Richardson, David; Nelson, Kate; Reynolds, Maria; Zografos, Laurie; Jean-Louis, Ashley; Garris, Cindy Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 883. Qualitative Patient-Participant Perspectives on Implementation of Monthly Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable in the United States (CUSTOMIZE). (4th December 2021) Authors: Garris, Cindy; Stassek, Larissa; D'Amico, Ronald; Dalessandro, Marybeth; Adkins, Sheila; Thedinger, Blair; Brock, James B; Chiriboga-Salazar, Daniela M; Czarnogorski, Maggie Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 883. Qualitative Patient-Participant Perspectives on Implementation of Monthly Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable in the United States (CUSTOMIZE). (4th December 2021) Authors: Garris, Cindy; Stassek, Larissa; D'Amico, Ronald; Dalessandro, Marybeth; Adkins, Sheila; Thedinger, Blair; Brock, James B; Chiriboga-Salazar, Daniela M; Czarnogorski, Maggie Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan. (May 2013) Authors: Garris, Cindy; Jhingran, Priti; Bass, Damon; Engel-Nitz, Nicole M.; Riedel, Aylin; Dennis, Greg Journal: Journal of medical economics Issue: Volume 16:Number 5(2013) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy. (1st February 2022) Authors: Mills, Anthony; Richmond, Gary J.; Newman, Cheryl; Osiyemi, Olayemi; Cade, Jerry; Brinson, Cynthia; De Vente, Jerome; Margolis, David A.; Sutton, Kenneth C.; Wilches, Viviana; Hatch, Sarah; Roberts, Jeremy; McCoig, Cynthia; Garris, Cindy; Vandermeulen, Kati; Spreen, William R. Journal: AIDS Issue: Volume 36:Number 2(2022) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗